A

Alto Neuroscience
D

ANRO

36.320
USD
2.14
(6.26%)
مغلق
حجم التداول
49,596
الربح لكل سهم
-3
العائد الربحي
-
P/E
-16
حجم السوق
1,425,273,217
المقالات
المزيد

العنوان: Alto Neuroscience

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.